Twist Bioscience has entered an agreement with Eli Lilly’s TuneLab, an AI/ML drug-discovery platform, to provide antibody characterization data for AI model development. 🔹 Key Highlights 🤝 Twist will provide high-quality antibody characterization data. 🧬 Data includes antibody developability and sequence-related information. 🤖 The data will support TuneLab’s AI models. 🔬 The collaboration aims to help researchers identify promising antibody candidates faster. 💊 The partnership could accelerate antibody drug discovery and pharmaceutical R&D. 💡 Why It Matters The partnership combines high-quality biological data with AI/ML capabilities, highlighting the increasing role of AI in accelerating antibody discovery and pharmaceutical research. 🚀 Start Your 7-Day FREE ThinkSabio Trial https://www.thinksabio.com/ ThinkSabio — Stocks Simplified